The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Neuropsychiatric Predictors of Progression from Amnestic-Mild Cognitive Impairment to Alzheimer's Disease: The Role of Depression and Apathy
Open accessAbstract
The aim of the study is to evaluate whether depression or apathy in patients with amnestic-mild cognitive impairment (MCI) increases the risk of progressing to Alzheimer's disease (AD). We investigated 131 consecutive memory-clinic outpatients with newly-diagnosed amnestic-MCI (mean age 70.8, SD=6.5). Psychiatric disorders were diagnosed at baseline according to the criteria for depression and apathy in AD. Neuropsychiatric symptoms were assessed with the Neuropsychiatric Inventory (NPI). Follow-up examinations were conducted after six months and annually for four years. Neurologists diagnosed AD at follow-up using NINCDS-ADRDA criteria. Cox proportional hazard models with 95% confidence intervals were used to test the hypothesis that apathy or depression increases the risk of developing AD. At baseline, 36.6% amnestic-MCI patients had a diagnosis of depression and 10.7% had apathy. Patients with both amnestic-MCI and an apathy diagnosis had an almost sevenfold risk of AD progression compared to amnestic-MCI patients without apathy (HR=6.9; 2.3-20.6), after adjustment for age, gender, education, baseline global cognitive and functional status, and depression. Furthermore, the risk of developing AD increased 30% per point on the NPI apathy item (HR=1.3; 1.1-1.4). There was no increased risk of developing AD in amnestic-MCI patients with either a diagnosis or symptoms of depression. In conclusion, apathy, but not depression, predicts which patients with amnestic-MCI will progress to AD. Thus, apathy has an important impact on amnestic-MCI and should be considered a mixed cognitive/psychiatric disturbance related to ongoing AD neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659 · cited 1×
“However, a recent meta-analysis [5] showed that annual conversion is greatly variable among studies, and lower than previously expected (8.”
Carlesimo, G. A., Caltagirone, C., Gainotti, G., Fadda, L., Gallassi, R., Lorusso, S., Marfia, G., Marra, C., Nocentini, U., & Parnetti, L. (1996) · European Neurology · doi:10.1159/000117297 · Cited by 1,234
Self-citationModrego, P. J., & Ferrández, J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1290 · Cited by 537
Geda, Y. E., Roberts, R. O., Knopman, D. S., Petersen, R. C., Christianson, T. J. H., Pankratz, V. S., Smith, G. E., Boeve, B. F., Ivnik, R. J., Tangalos, E. G., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1193 · Cited by 438
Predictors of progression from mild cognitive impairment to Alzheimer disease
Palmer, K., Berger, A. K., Monastero, R., Winblad, B., Bäckman, L., & Fratiglioni, L. (2007) · Neurology · doi:10.1212/01.wnl.0000260968.92345.3f · Cited by 438
Self-citationSyndromic Validity of Apathy in Alzheimer’s Disease
Starkstein, S. E., Petracca, G., Chemerinski, E., & Kremer, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.872 · Cited by 392
Neuropsychiatric Manifestations in Mild Cognitive Impairment: A Systematic Review of the Literature
Apostolova, L. G., & Cummings, J. L. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000112509 · Cited by 391
Cited by
Behavioral and psychological symptoms of dementia
Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00073 · Cited by 1,425
“On the other hand, the presence of specific symptoms can aggravate cognitive decline; patients who present with both amnestic-MCI and apathy, but not those with depression, had an almost seven-fold risk of AD progression compared to amnestic-MCI patients without apathy, after adjustment of variables (Palmer et al., 20…”
ResultCooper, C., Sommerlad, A., Lyketsos, C. G., & Livingston, G. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070878 · Cited by 570
Ismail, Z., Elbayoumi, H., Fischer, C. E., Hogan, D. B., Millikin, C. P., Schweizer, T., Mortby, M. E., Smith, E. E., Patten, S. B., & Fiest, K. M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3162 · Cited by 532
Ward, A., Tardiff, S., Dye, C., & Arrighi, H. M. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000354370 · Cited by 426
Robb, C. E., de Jager, C. A., Ahmadi-Abhari, S., Giannakopoulou, P., Udeh-Momoh, C., McKeand, J., Price, G., Car, J., Majeed, A., Ward, H., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.591120 · Cited by 427
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y.-K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 410
Late-life depression, mild cognitive impairment, and dementia
Richard, E., Reitz, C., Honig, L. H., Schupf, N., Tang, M. X., Manly, J. J., Mayeux, R., Devanand, D., & Luchsinger, J. A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.603 · Cited by 389
“We could not confirm the association of apathy with an increased risk of progressing from MCI to dementia, but we did not perform an extensive apathy evaluation.(38) Our study has several limitations.”
MethodNeuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
Geda, Y. E., Schneider, L. S., Gitlin, L. N., Miller, D. S., Smith, G. S., Bell, J., Evans, J., Lee, M., Porsteinsson, A., Lanctôt, K. L., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.12.001 · Cited by 378
“[36] Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G,”
BackgroundVascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7a4 · Cited by 367
The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease
Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Geda, Y. E., & Lyketsos, C. G. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.006 · Cited by 366
“The added risk can be substantial: for example, in one study the presence of apathy increased the risk of incident dementia seven-fold (13).”
BackgroundGeda, Y. E., Roberts, R. O., Mielke, M. M., Knopman, D. S., Christianson, T. J. H., Pankratz, V. S., Boeve, B. F., Sochor, O., Tangalos, E. G., Petersen, R. C., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13060821 · Cited by 336
Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives
Ma, L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00009 · Cited by 323
Coyle, H., Traynor, V., & Solowij, N. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.04.009 · Cited by 274
Mourao, R. J., Mansur, G., Malloy‐Diniz, L. F., Castro Costa, E., & Diniz, B. S. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4406 · Cited by 256
Ismail, Z., Gatchel, J., Bateman, D. R., Barcelos-Ferreira, R., Cantillon, M., Jaeger, J., Donovan, N. J., Mortby, M. E., & Mortby, M. E. (2018) · International Psychogeriatrics · doi:10.1017/s1041610217001880 · Cited by 221
Rodakowski, J., Saghafi, E., Butters, M. A., & Skidmore, E. R. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.003 · Cited by 212
Bartels, C., Wagner, M., Wolfsgruber, S., Ehrenreich, H., Schneider, A., & Initiative, F. T. A. D. N. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040404 · Cited by 202
Rosenberg, P. B., Mielke, M. M., Han, D., Leoutsakos, J. S., Lyketsos, C. G., Rabins, P. V., Zandi, P. P., Breitner, J. C. S., Norton, M. C., Welsh‐Bohmer, K. A., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3769 · Cited by 127
“The NPI has been widely used for quantifying neuropsychiatric symptoms in AD in observational studies (Palmer et al., 2010) and in recent clinical trials (Porsteinsson et al.”
New Research on Anxiety Disorders in the Elderly and an Update on Evidence-Based Treatments
Andreescu, C., & Varon, D. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0595-8 · Cited by 85
Apathy is associated with increased amyloid burden in mild cognitive impairment
Marshall, G. A., Donovan, N. J., Lorius, N., Gidicsin, C. M., Maye, J., Pepin, L. C., Becker, J. A., Amariglio, R. E., Rentz, D. M., Sperling, R. A., et al. (2013) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.12060156 · Cited by 73
Structural MRI correlates of apathy symptoms in older persons without dementia: AGES-Reykjavik Study
Grool, A. M., Geerlings, M. I., Sigurdsson, S., Eiriksdottir, G., Jonsson, P. V., Garcia, M. E., Siggeirsdottir, K., Harris, T. B., Sigmundsson, T., Gudnason, V., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000378 · Cited by 73
“This hypothesis is supported by studies that identified apathy as an early neuropsychiatric symptom in patients with mild cognitive impairment and dementia,(35) but also as a risk factor for progression to dementia in patients with subjective memory problems and mild cognitive impairment.(36,37) Clearly, prospective s…”
ResultZahodne, L. B., Gongvatana, A., Cohen, R. A., Ott, B. R., & Tremont, G. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.043 · Cited by 72
“Inclusion criteria for all participants in ADNI-1 were: (1) Hachinski score ≤4; (2) age between 55 and 90; (3) stability of permitted medications for 4 weeks; (4) Geriatric Depression Scale score <6; (5) study partner with 10+ hr/wk contact; (6) adequate visual and auditory acuity; (7) good general health; (8) inabili…”
BackgroundBanks, S. J., Raman, R., He, F., Salmon, D. P., Ferris, S., Aisen, P., & Cummings, J. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000357775 · Cited by 68
Suicide and chronic traumatic encephalopathy
Iverson, G. L. (2016) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15070172 · Cited by 66
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study
Delrieu, J., Desmidt, T., Camus, V., Sourdet, S., Boutoleau‐Bretonnière, C., Mullin, E., Vellas, B., Payoux, P., Lebouvier, T., & Initiative, A. D. N. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4161 · Cited by 66
Goukasian, N., Hwang, K. S., Romero, T., Grotts, J., Do, T. M., Groh, J. R., Bateman, D. R., & Apostolova, L. G. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031947 · Cited by 64
Guercio, B. J., Donovan, N. J., Ward, A., Schultz, A., Lorius, N., Amariglio, R. E., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13060141 · Cited by 61
Wiels, W. A., Wittens, M. M. J., Zeeuws, D., Baeken, C., & Engelborghs, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707580 · Cited by 52
Metadata
- Authors
- Palmer, K., Di Iulio, F., Varsi, A. E., Gianni, W., Sancesario, G., Caltagirone, C., & Spalletta, G.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-03-24
- Volume
- 20
- Issue
- 1
- Pages
- 175-183
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2162880095
- Cited by
- 290
- References
- 27
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.